Overview
Blood Sample Collection Research Study for Ovarian Cancer
Ovarian cancer (OC) is a life-threatening human disease, the most lethal gynecologic cancer. At current, there is no reliable test available for diagnosing early-stage OC.
The study sponsor is in the process of developing noninvasive blood tests which can accurately identify which participants are at high or low risk of ovarian cancer.
About the Study
The objective of this protocol is to collect and bank blood samples from symptomatic women in order to support research and development activities focused on the analytical performance evaluation of the study sponsor’s investigational ovarian cancer assay. Samples obtained will be utilized for assay optimization, reproducibility testing, and performance characterization.
Who Can Join
You may be eligible to participate if you:
- Are biologically female and at least 22 years old
- Have at least one ovary
- Have one or more of the following symptoms:
- Abdominal/pelvic pain
- Feeling full quickly or inability to eat normally
- Abdominal bloating/increased abdominal size
You may not be eligible if you:
- Are pregnant
- Have been diagnosed with any cancer within the past five (5) years, (excluding non-melanoma skin cancers)
- Are undergoing chemotherapy or radiation treatment
*Additional criteria may apply
Not sure if you qualify?
A member of our study team will review your medical history and medications with you to determine if this study may be a good fit.
What to Expect
Study Duration and Study Visits
Only one single study visit will occur.
This study will collect an initial 40 mL whole blood sample from each participant.